About Global Photon
Global Photon is a company based in Austin (United States) founded in 2004 by Brad Richdale. It operates as a B2B. Global Photon has raised $50 thousand across 2 funding rounds. Global Photon operates in a competitive market with competitors including PhotoPharmics, Norlase, CranioVation, Adgero Biopharma and Lumeda, among others.
- Headquarter Austin, United States
- Founders Brad Richdale
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 K (USD)
in 2 rounds
-
Latest Funding Round
$25 K (USD), Seed
Jul 18, 2012
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Global Photon
Global Photon has successfully raised a total of $50K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $25 thousand completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Global Photon
Investment portfolio details for Global Photon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Global Photon
Detailed financials for Global Photon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Global Photon Comparisons
Peer comparison for Global Photon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Global Photon
Global Photon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Norlase, CranioVation, Adgero Biopharma and Lumeda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Provider of low-level laser therapy systems
|
|
| Locked | Locked | Locked |
Minimally invasive devices for brain tumor treatment are provided.
|
|
| Locked | Locked | Locked |
Photodynamic therapy for cutaneous metastatic breast cancer is developed.
|
|
| Locked | Locked | Locked |
Photodynamic therapy device for lung cancer treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of a drug delivery platform for the treatment of solid tumors
|
Detailed competitors of Global Photon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Global Photon
Complete news archive for Global Photon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Global Photon
Global Photon was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Global Photon is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Brad Richdale is the current CEO of Global Photon. They have also founded this company.
Global Photon is a funded company, having raised a total of $50K across 2 funding rounds to date.
Global Photon develops phototherapy devices designed for chemotherapy patients through providing healthcare solutions, developing medical devices, phototherapy, and oncology treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Global Photon's top competitors include PhotoPharmics, Norlase and ImPact Biotech.